Suven Life Sciences Limited
USPTO PatentsView assignee record - 30 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Suven ranks #10,469 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 7 technology areas.
- #10,469
- of 49,997 US assignees by volume
- Top 39%
- by Innovation Score (39.1/100)
- 14.3
- avg claims per patent
- -33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R10469 · Foreign Corporation #10,469 · 30 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 30 grants
- UPPER-Q #10,469/49,997
- PHOTO-FINISH SanBio
- CPC-NARROW A61P · 7 areas
- INNOV-THIN 39.1/100
- CLAIMS-RICH 14.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: SanBio, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Suven’s 39.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Suven
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Jiangsu Hecheng… · near
Jiangsu Hecheng… · near
39 score
- Raycan Technology… · near
Raycan Technology… · near
39 score
- Roche Diagnostics… · near
Roche Diagnostics… · near
39 score
- Snipr · near
Snipr · near
39 score
- Suven Life Sciences · this assignee
Suven Life Sciences · this assignee
39 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Suven's Innovation Score is 39.1/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Suven?
Each dot is one of Suven’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Suven’s own 14.3 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Suven's grants concentrate
Suven Life Sciences Limited is a focused PatentsView assignee: 7 CPC subclasses with 90% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (5 grants) versus a trough of 1 in 2023. By volume, Suven sits between Soilmec S.P.A. and Sequent Medical, Inc..
Suven's three-year grant acceleration
Suven Life Sciences Limited shows 7 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Suven's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Soilmec S P A
Soilmec S.P.A.
30 patents
- Sonendo
Sonendo, Inc.
30 patents
- SPX Cooling
SPX Cooling Technologies, Inc.
30 patents
- Structured I
Structured I, LLC
30 patents
- Sanbio
SanBio, Inc.
30 patents
- Sensible Medical…
Sensible Medical Innovations Ltd.
30 patents
- Sentry Solutions…
Sentry Solutions Products Group LLC
30 patents
- Sequent Medical
Sequent Medical, Inc.
30 patents
- Suven Life Scienc… ◀
Suven Life Sciences Limited
30 patents
What this shows Suven holds 30 patents at rank #10,456, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Suven
By rank, the assignees closest to #10,456 in granted patent volume.
- Soilmec S.P.A. #10,452 · 30 patents
- Sonendo, Inc. #10,453 · 30 patents
- SPX Cooling Technologies, Inc. #10,454 · 30 patents
- Structured I, LLC #10,455 · 30 patents
- SanBio, Inc. #10,457 · 30 patents
- Sensible Medical Innovations Ltd. #10,458 · 30 patents
- Sentry Solutions Products Group LLC #10,459 · 30 patents
- Sequent Medical, Inc. #10,460 · 30 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Suven's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Suven, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Suven ranks #737 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (39 here).
Suven's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
39 Top 39% higher than 61% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 10.0% |
| 2016 | 2 | 6.7% |
| 2017 | 5 | 16.7% |
| 2018 | 3 | 10.0% |
| 2019 | 2 | 6.7% |
| 2021 | 3 | 10.0% |
| 2022 | 4 | 13.3% |
| 2023 | 1 | 3.3% |
| 2024 | 2 | 6.7% |
| 2025partial year | 5 | 16.7% |
Which technologies does Suven Life Sciences Limited patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Suven Life Sciences Limited's patent record in context - here's where to go next.
- Suven Life Sciences Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 90% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #10,469 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Suven Life Sciences Limited against Soilmec S.P.A., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 39.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.